Child Survival Working Group
Accessed: 18.10.2019
F1000Research 2019, 8:323 Last updated: 17 MAY 2019
Accessed: 08.10.2019
Based on the National Guidelines for the Management of Tuberculosis in Children 2013, Department of Health, South Africa.
Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...of Congo, Eswatini, Guinea, Kenya, Malawi, Mozambique, Myanmar and Zimbabwe. With a focus on the financial resources available, this report highlights the current risks and gaps in HIV and TB service delivery in these countries.
Given the findings of gaps in diagnosis, prevention and care services and dwindling resources, MSF calls for a robust assessment of the needs and the resource capacity of each affected country, and calls on international donors to ensure that the financial burden is shared, rather than shifted onto those countries worst affected by the diseases.
more
Child Survival Working Group
Accessed: 26.10.2019
Final Report
Submitted to: Unicef, New Delhi
ORG Centre for Social Research (A Division of AC Nielsen ORG- MARG Private Limited)
Accessed: 30.10.2019
PLOS ONE | https://doi.org/10.1371/journal.pone.0217693 June 7, 2019
With focus on creating linkages between social cash transfer programmes and HIV services
Accessed: 21.08.2019
Journal of Infection and Public Health 12 (2019) 213–223
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
Regional Factsheets
HIV and AIDS Estimates
Accessed: 29.09.2019
Russian Federation
Accessed: 24.09.2019
World Aids Day, 1. December 2018
Commemorating 30 Years
Accessed: 05.10.2019